Bio Product Guide » anti-CD3 monoclonal antibody http://www.bioproductguide.com/blog A comprehensive guide to bio products for medical professionals Fri, 11 Jun 2010 08:56:43 +0000 http://wordpress.org/?v=2.8.2 en hourly 1 PDL BioPharma Announces New Licensing Agreement With Eli Lilly http://www.bioproductguide.com/blog/2009/12/22/pdl-biopharma-announces-new-licensing-agreement-with-eli-lilly/ http://www.bioproductguide.com/blog/2009/12/22/pdl-biopharma-announces-new-licensing-agreement-with-eli-lilly/#comments Tue, 22 Dec 2009 09:42:27 +0000 Jim Marino http://www.bioproductguide.com/blog/?p=209 PDL BioPharmaPDL BioPharma, Inc. has announced that it has entered into a non-exclusive license agreement with Eli Lilly and Company under PDL’s Queen et al patents with respect to teplizumab, a humanized anti-CD3 monoclonal antibody, as well as other potential next generation anti-CD3 molecules. Teplizumab is currently being studied by Lilly and its partner MacroGenics for the treatment of individuals with newly-diagnosed type 1 diabetes mellitus. No other details of the licensing agreement were made available.

For the full story, Click Here

]]> http://www.bioproductguide.com/blog/2009/12/22/pdl-biopharma-announces-new-licensing-agreement-with-eli-lilly/feed/ 0